On June 12, 2023, the list of "18th China Listed Companies Competitive Credibility Company" organized by Chinese Securities Journal was announced. Shanghai Medicilon Inc. (Medicilon) was awarded the "2023 Growth Potential Company" by virtue of its stable and excellent profitability, innovation ability, and competitive strength.